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Abstract
Background: The present study describes the epidemiological status of sexually transmitted infections (STIs) in Iran based on the Global 
Burden of Disease study 2010 (the GBD 2010), and compares this with those of other neighboring countries.
Methods: The burden of STIs from 1990 to 2010 in Iran was derived from a systematic study, namely the GBD 2010, which was conducted 
by the Institute for Health Metrics and Evaluation (IHME). Using a model-based estimation, Disability Adjusted Life Years (DALYs) were 
calculated on the basis of the prevalence of STIs. The GBD 2010 used disability weights, and a mortality rate that was obtained from the 
vital registration system of Iran. We review the results of the GBD 2010 estimations for STIs in Iran.
Results: The trend of DALYs attributable to STIs (107.3 and 26.47 per 100,000 people in 1990 and 2010, respectively) and deaths (1.13 
and 0.12 per 100,000 people in 1990 and 2010, respectively) decreased dramatically in Iran during the last two decades. The majority of 
individuals affected by STI DALYs were aged 1 – 4 and 20 – 24 years.
Conclusion: Since the majority of DALYs attributed to STIs were observed among those aged 1 – 4 years and young people, the 
economic burden of STIs will remain high in Iran. Therefore, effective evidence-based planning is critical to allocate the essential budget for 
utilizing treatment and prevention approaches.
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Introduction
S exually transmitted infections (STIs) are currently a major worldwide public health problem,1 and the incidence rate is 
increasing in developed countries.2–4  In 2008, approximately, 
498.9 million new cases of STIs, including chlamydia trachomatis, 
neisseria gonorrhea, syphilis, and trichomonas vaginalis occurred 
globally in the reproductive age group. This was 11% higher than 
the estimations provided for 2005. The Global Burden of Disease 
study 2010 (the GBD 2010) has reported a growth of 16.9% in the 
years lived with disability (YLD) due to STIs between 1990 and 
2010.5 Although STI surveillance data usually underestimate the 
burden of this group of diseases,6 the World Health Organization 
has estimated the total global number of new cases in adults to be 
approximately 266.1 and 232.8 million in males and females, 
respectively.1
One study showed that the proportion of chlamydia trachomatis 
(CT) infection among women with cervicitis was 12% – 25% in 
Tehran (the capital city of Iran) in 2006. The majority (49%) of CT-
positive samples were in women in the 31 – 40 years age group, 
followed by those aged 20 – 30 years (33%). This frequency was 
higher than the previous reported rate in Iran (7%).7 Also, another 
study showed that the overall prevalence of STI and its syndromes 
(even genital ulcer or vaginal discharge) was 7% – 18% and 36%, 
respectively, in female sex workers aged 18 years or older, in 
Kerman province.8 Between 2009 and 2010, the prevalence rate 
of CT among women with illegal social behaviors (prostitutes) 
in Isfahan province was 19.8%,9 and the prevalence of syphilis 
in female sex workers in Kerman province was 7.2%  rates that 
were far higher than those observed in the general population 
(less than 1%).8 In a study of women of reproductive age in Rasht 
city, the prevalence of gonococci was estimated at 0.6%,10 while 
in a separate study that was conducted in Tehran, gonococci, 
CT and trichomonas vaginitis were reported in 2%, 5.3%, and 
4% of women, respectively.11 However, prevalence rates of 
candidiasis, trichomoniasis, and bacterial vaginitis among women 
with vaginitis in Hamedan city were 17.2%, 18.1%, and 28.5%, 
respectively.12
Since STIs are the common cause of mortality, and numerous 
morbidities among people in developing countries,13,14 
determination of the magnitude of their burden appears to be a 
necessity for health service planning15 and monitoring, as well 
Burden of Sexually Transmitted Infections in Iran from 1990 to 
2010: Results from the Global Burden of Disease study 2010
Shadi Rahimzadeh MSc PhD Candidate1,2, Shohreh Naderimagham MPH PhD1,3, Marzieh Rohani-Rasaf MSc PhD Candidate2, Parinaz 
Mehdipour MSc1,30DVRXG/RW¿]DGHK3K'4, Sharareh R. Niakan Kalhori PhD1,5, Fereshteh Davoudi BSc2, Atefeh Noori MSc1,3, 
Kianoush Kamali MD6, Seyed Saeed Hashemi Nazari MD  MPH  PhD•2,7
$XWKRUV¶ DI¿OLDWLRQV 1Non-communicable Diseases Research Center, 
Endocrinology and Metabolism Population Sciences Institute, Tehran University 
of Medical Sciences, Tehran, Iran, 2Departement of Epidemiology, Shahid 
Beheshti University of Medical Sciences, Tehran, Iran, 3Endocrinology and 
Metabolism Research Center, Endocrinology and Metabolism Research 
Institute, Tehran University of Medical Sciences, Tehran, Iran, 4Department of 
Community Health, Shahrekord University of Medical Sciences, Shahrekord, 
Iran, 5Department of Health Information Management, School of Allied Medical 
Sciences, Tehran University of Medical Sciences Tehran, Iran, 6Iran Ministry 
of Health and Medical Education, Tehran, Iran, 7Safety Promotion and Injury 
Prevention Research Center, Shahid Beheshti University of Medical Sciences, 
Tehran, Iran.
•Corresponding author and reprints: Seyed Saeed Hashemi Nazar MD MPH
PhD, Safety Promotion and Injury Prevention Research Center, Department of 
Epidemiology, School of Public Health, Shahid Beheshti University of Medical 
Sciences, Tehran, Iran. E-mail: saeedh_1999@sbmu.ac.ir.
Accepted for publication: 24 August 2016
Archives of Iranian Medicine, Volume 19, Number 11, November 2016 769
S. Rahimzadeh, S. Naderimagham, M. Rohani-Rasaf, et al.
as supporting prevention programs at a national level.16 To date, 
few previous studies have estimated the burden of STIs due to the 
absence of community-based data on sexual factors,17,18 technical 
demands, costs, and administration problems.19 Therefore, by 
using the GBD 2010 results, the present investigation described 
the magnitude of the burden of STIs, including syphilis, gonorrhea, 
chlamydia and trichomoniasis, and their sequelae, by estimating 
incidence, mortality, and disability adjusted life years (DALYs) 
in Iran.
Methods
The general information regarding data, statistical modeling, and 
metrics for the GBD 2010 have been described elsewhere.20–26 In 
summary, the GBD 2010 study listed 291 diseases and injuries in 
20 age groups, and both genders for 187 countries, and used several 
measures to report results, including deaths, YLLs, YLDs, and 
DALYs rates. YLLs were calculated via multiplying the number 
of deaths in each age group by a reference life expectancy for that 
age group.24 YLDs were calculated according to the prevalence 
of a disease multiplied by the disability weight for that disease. 
Disability weights were scaled from 0 to 1, whereby 0 implies full 
health and 1 means a healthy state that is equivalent to death.25 The 
sum of these two indices was used to develop DALYs. Moreover, 
WKHXQFHUWDLQW\IRUHDFKFDXVHVSHFL¿F'$/<ZDVFDOFXODWHGE\
combining uncertainty at the levels of all-cause mortality, cause-
VSHFL¿FPRUWDOLW\SUHYDOHQFHDQGGLVDELOLW\ZHLJKWV23
The estimates were prepared on the basis of a database for all 
age-gender-country-year groups for the majority of diseases, with 
a Bayesian meta-regression method established for the GBD 2010 
(DisMod-MR),27 in which prevalence, incidence, remission, and 
excess mortality estimations were calculated for each disease, 
via a systematic analysis of published and available unpublished 
data sources.22 Estimates for causes of deaths were obtained from 
a comprehensive database of vital registration, verbal autopsy, 
surveillance, and other sources, covering 187 countries from 1980 
to 2010.23
Cause of Death Ensemble modeling was used for numerous 
causes of death25 but for a few selected causes, including STIs, 
a combination of methods was designed to derive estimations of 
67,EXUGHQDQGPRUWDOLW\IRUWKH¿UVWWLPH,WLVZRUWKPHQWLRQLQJ
that, according to the GBD 2010, the majority of information for 
estimating STI prevalence and incidence for the countries without 
original data, such as Iran was gained by multiplication of imputed 
data from other countries.
However, in the present study, data related to STIs in Iran was 
extracted using the GBD 2010 (released 2013). Also, data was 
described using new graphs and tables, and GBD 2010 results 
were reviewed.
Results
There was an overall decrease in the STI death rate (1.13 to 0.12 
per 100,000 people) across all age groups and both genders over 
the 20-year study period. The syphilis death rate was reduced by 
approximately 1 per 100,000 in all age groups and both genders, 
but after standardizing by age, the decrease was even greater 
(0.70 to 0.12). For chlamydial and gonococcal diseases, age 
standardized death rates were reduced by around 0.012 – 0.005 
and 0.009 – 0.004, respectively, from 1990 to 2010 (Table 1, 
Figure1).
In 1990 and 2010, total death rates were not remarkable in any 
age groups except for children aged 1 – 4 years and people aged 
over 65 years (Figure 2). Death rates were higher in males than 
females in both 1990 (females: 0.7, males: 0.79 per 100,000 
people) and 2010 (females: 0.14, Males: 0.16 per 100,000 people) 
(Figure 3).
Overall DALY rate (107.3 to 26.47 per 100,000) dramatically 
decreased during the 20-year study period (Table 1), but was 
different for each type of disease. For syphilis and trichomoniasis, 
the age standardized DALYs rate decreased from 54.96 to 9.06 
and 2.97 to 1.98 per 100,000, respectively. It increased slightly 
from 6.69 to 6.77 per 100,000 for chlamydia. The DALYs rate 
decreased by approximately 0.05 per 100,000 due to gonococcal 
disease, and slightly increased in those aged 5 – 49 years (Table 2). 
With regard to age, the total DALYs rate was the highest in those 
DEATH (#*) DALY(#)
1990 Upper Lower 2010 Upper Lower 1990 Upper Lower 2010 Upper Lower
Under 5 565.056 920.427 312.57 52.7546 110.007 20.556 48477 78962 26815 4527 9442.2 1764
5–14 years 14.6594 22.9363 8.7604 1.61583 3.03267 0.7465 1468 2204 922.7 380.8 654.59 196.18
15–49 years 11.5147 17.5657 4.9017 8.80507 13.5474 4.2407 7990 15021 3942 13791 26472 6378.5
50–69 years 15.4554 27.7184 5.5393 10.0804 17.4189 4.5327 652.5 1120 289.9 581.4 994.78 291.52
70+ years 13.9261 24.024 4.9163 20.2188 34.189 8.6902 219 370.8 89.23 300.3 479.75 151
All Ages 620.611 975.145 365.54 93.4746 154.306 52.801 58807 89717 35435 19580 32994 10817
DEATHs (Rate**) DALY(Rate)
1990 Upper Lower 2010 Upper Lower 1990 Upper Lower 2010 Upper Lower
Under 5 6.1818 10.0698 3.4196 0.8593 1.7919 0.3348 530.4 863.9 293.4 73.74 153.81 28.735
5–14 years 0.0922 0.1443 0.0551 0.0149 0.028 0.0068 9.239 13.87 5.808 3.519 6.0482 1.8127
15–49 years 0.0482 0.0736 0.0205 0.0192 0.0296 0.0092 33.51 63 16.53 30.19 57.949 13.963
50–69 years 0.3085 0.5533 0.1105 0.1161 0.2006 0.0522 13.03 22.37 5.787 6.698 11.46 3.3583
70+ years 1.478 2.5498 0.5218 0.7658 1.295 0.3291 23.24 39.36 9.47 11.38 18.172 5.7198
All Ages 1.132 1.7787 0.6667 0.1263 0.2086 0.0713 107.3 163.7 64.64 26.47 44.609 14.624
*Number of death and DALY; **Rate per 100,000
Table 1. Death & DALY statistics related to sexually transmitted infections by age groups from 1990 to 2010
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Figure 1. Trends of DALY and death rates of sexually transmitted infections by disease from 1990 to 2010
Figure 2. DALY and Death rates for sexually transmitted infections by age groups in 1990 and 2010
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Figure 3. DALY and Death rates of Sexually Transmitted Infections by sex in 1990 and 2010
DEATHs DALY
1990 2000 2010 1990 2000 2010
Syphilis
Under 5 6.1818 1.8734 0.8593 530.358 160.739 73.7377
5–14 years 0.0896 0.0219 0.0135 7.0685 1.7459 1.0798
15–49 years 0.0319 0.0204 0.0128 3.4193 2.4737 1.8923
50–69 years 0.2264 0.1431 0.0793 9.7695 6.7546 4.5729
70+ years 1.0298 0.6775 0.5147 17.4964 11.8525 8.3988
All Ages 1.1089 0.2312 0.1089 93.1565 18.4911 8.2834
Age-standardized 0.7049 0.2585 0.1276 54.9613 18.8912 9.0654
Chlamydial disease
5–14 years 0.0006 0.0005 0.0003 1.0096 1.2876 1.2544
15–49 years 0.0038 0.0027 0.0015 13.3272 13.6057 13.5823
50–69 years 0.0196 0.0142 0.0087 0.7286 0.6186 0.4887
70+ years 0.1062 0.0750 0.0594 1.3065 0.9200 0.6641
All Ages 0.0054 0.0048 0.0041 6.1781 7.7142 8.6532
Age-standardized 0.0123 0.0087 0.0055 6.6948 6.7932 6.7763
Gonococcal infection
5–14 years 0.0004 0.0004 0.0002 0.5168 0.6363 0.6140
15–49 years 0.0028 0.0020 0.0011 7.4887 7.4715 7.6361
50–69 years 0.0144 0.0105 0.0064 0.5198 0.4396 0.3522
70+ years 0.0792 0.0560 0.0444 0.9655 0.6779 0.4879
All Ages 0.0040 0.0036 0.0030 3.4710 4.2350 4.8648
Age-standardized 0.0091 0.0064 0.0041 4.0356 4.0080 3.9894
Trichomoniasis
5–14 years 0 0 0 0.3940 0.4120 0.3263
15–49 years 0 0 0 5.9497 4.8406 3.9356
50-69 years 0 0 0 0.3687 0.3132 0.2655
70+ years 0 0 0 0.2753 0.2157 0.1776
All Ages 0 0 0 2.7404 2.7413 2.5159
Age-standardized 0 0 0 2.9768 2.4241 1.9817
Table 2. Death & DALY rates (per 100000 population) related to chlamydia, gonorrhea, trichomonasis and syphilis by age groups from 1990 to 2010
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aged 1 – 4 years, then decreased   within the age range of 5 – 14 
years, and then again increased dramatically, peaking in the 20 – 
24 years age group. At this point, the death rate then decreased 
up to the age of 60 years, and then increased after the age of 65 
years. DALYs rates were higher in males than females in both 
1990 (females: 69.7, males: 72.1 per 100,000 people) and 2010 
(females: 22.8, males: 24.5 per 100,000 people) (Figures 2 and 3).
Discussion
According to our results, the numbers and rates of deaths due to 
STIs dramatically decreased in all age groups from 1990 to 2010. 
Surprisingly, the highest rates of deaths were observed among 
children younger than 5 years and people aged over 60 years. 
While the maximum DALYs rates were observed in children 
aged less than 5 years, followed by people aged 15 to 49 years, as 
the most sexually active group. Since children aged under 5 years 
are not sexually active, it appears that the high death rates could 
be related to abortions due to STIs, especially maternal syphilis 
seroreactivity.28 Therefore, urgent intervention during pregnancy 
is required to prevent transmission of the aforementioned 
infections in children.
In a similar manner to the death rates, trends of rates and numbers 
of DALYs were also decreasing in nature from 1990 to 2010 
in Iran, and the highest rate of DALYs was related to children 
under the age of 5 years. Despite the trend toward a decrease, 
higher rates of DALYs and death among these children highlight 
the need to pay greater attention to this age group as the most 
vulnerable population in Iran, and to expand proper interventions 
to reduce the burden of STIs among younger people. It should 
be noted that, according to the report of the Ministry of Health 
and Medical Education (MoHME), there was a trend toward 
increased STI incidence from 1998 to 2005, and this was greater 
in people aged 20 – 29 years than in those in other age groups.29 
The observed inconsistency between results could be related to 
the different methodologies used in these two reports. 
The comparison between the four most prevalent STIs in terms 
of deaths and DALYs rates demonstrated higher worldwide values 
for syphilis followed by chlamydia, gonorrhea, and trichomoniasis. 
Since syphilis showed a more remarkable decrease than other 
diseases, it received a great deal of attention among total STIs. 
Therefore, to control the burden of STIs in Iran, it seems rational 
to place a greater focus on syphilis than the other STIs. However, 
the need to address the latter, in terms of preventive and curative 
activities, should not be overlooked. 
Despite the decreasing death rate due to chlamydia, it should 
be mentioned that the DALYs rate attributed to this infection 
increased from 1990 to 2010. This demonstrates that although 
death caused by chlamydia was reduced, this infection made a 
greater impact on the lives of those affected. This highlights the 
need for urgent intervention to control the burden of chlamydia in 
Iran. In addition, although the estimated death rate attributable to 
trichomoniasis was zero from 1990 to 2010, the observed DALYs 
rate showed that this infection should still be considered as an 
active STI in Iran. 
When making a comparison with neighboring countries, the burden 
of STIs in Iran is similar to that found in Turkey (32.14 DALYs per 
100,000 people in 2010 vs. 23.73 per 100,000 people in Iran), but is 
far lower than that observed in Pakistan (99.14 DALYs per 100,000 
people in 2010). Overall, compared with developing and developed 
countries, the age-standardized DALYs rate in Iran is similar to that 
of developed countries (20.38 per 100,000 people in 2010) and far 
lower than that of developing countries (170.51 per 100,000 people 
in 2010).30 2Q WKHEDVLVRI WKHVH¿QGLQJV LW DSSHDUV WKDW FXOWXUDO
status and health education in Iran is in a better condition than in 
other developing countries. However, further studies with a greater 
number of details, using national and sub-national data, should be 
conducted to specify burden estimation.
Although the GBD 2010 is important, it has some limitations, and 
these have been explained elsewhere.20–26 For example, the IHME 
did not use the real data, and the results are based on modeling using 
imputed data. In addition, they did not estimate the measures at the 
subnational level and the results are not appropriate for planning 
health interventions and allocating resources in Iran. Therefore, 
health policy-makers must calculate the information regarding 
the burden of diseases at sub-national level to monitor the major 
KHDOWKULVNIDFWRUVRI67,VGHWHUPLQHSULRULWLHV¿[LQWHUYHQWLRQ
strategies, and check policy implementation at national and sub-
national levels to prevent STIs in Iran.
In this regard, due to the importance of estimating the burden 
of diseases, injuries, and risk factors, at both national and sub-
national levels in Iran, as well as the aforementioned limitations of 
the GBD 2010, the National and Sub-national Burden of Diseases 
(NASBOD), which is a systematic comprehensive study,31 is 
currently underway in that country. The NASBOD is using a 
standardized protocol of data collection, statistical methods, and 
estimation processes to calculate the burden of diseases, injuries, 
and risk factors at national and sub-national levels from 1990 
WR 7KLV VWXG\ LV EHQH¿WLQJ IURP WZRDGYDQFHG VWDWLVWLFDO
methods for calculation.32–33 In addition, it provides appropriate 
information for estimating health status in a single province or 
across provinces. The details of the NASBOD infectious diseases 
study protocol have been published elsewhere.34
In conclusion, on the basis of the GBD 2010 results, it appears 
that the deaths and the DALYs rates attributed to STIs are 
GHFUHDVLQJLQ,UDQZKLFKGHPRQVWUDWHVWKHHI¿FDF\RIORQJWHUP
efforts made by the country’s healthcare system to reduce the 
burden of STIs. However, the trend toward an increasing DALYs 
rate of chlamydia highlights the need for more preventative and 
curative interventions for STIs in Iran. 
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